| | | Single nucleotide variant (5 prime UTR variant) | LRRC8A-related condition +1 more | |
| | | Single nucleotide variant (synonymous variant) | LRRC8A-related condition +2 more | |
| | | Single nucleotide variant (synonymous variant) | LRRC8A-related condition +1 more | |
| | | Single nucleotide variant (missense variant) | LRRC8A-related condition +1 more | |
| | | Single nucleotide variant (synonymous variant) | LRRC8A-related condition +1 more | |
| | | Single nucleotide variant (synonymous variant) | LRRC8A-related condition +1 more | |
| | | Single nucleotide variant (synonymous variant) | not provided +1 more | |
| | | Single nucleotide variant (missense variant) | LRRC8A-related condition | |
| | | Single nucleotide variant (synonymous variant) | LRRC8A-related condition +1 more | |
| | | Single nucleotide variant (synonymous variant) | LRRC8A-related condition +1 more | |
| | | Single nucleotide variant (synonymous variant) | LRRC8A-related condition +1 more | |
| | | Single nucleotide variant (missense variant) | LRRC8A-related condition +1 more | |
| | | Single nucleotide variant (synonymous variant) | LRRC8A-related condition +2 more | |
| | | Single nucleotide variant (missense variant) | Agammaglobulinemia 5, autosomal dominant +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not provided +2 more | |
| | | Single nucleotide variant (missense variant) | LRRC8A-related condition +2 more | |
| | | Single nucleotide variant (synonymous variant) | LRRC8A-related condition +1 more | |
| | | Single nucleotide variant (synonymous variant) | LRRC8A-related condition +2 more | |
| | | Single nucleotide variant (synonymous variant) | not provided +2 more | |
| | | Single nucleotide variant (synonymous variant) | not provided +1 more | |
| | | Single nucleotide variant (missense variant) | LRRC8A-related condition +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | LRRC8A-related condition +1 more | |